000 04302nam a22005657a 4500
001 sulb-eb0024097
003 BD-SySUS
005 20160413122424.0
007 cr nn 008mamaa
008 121026s2013 gw | s |||| 0|eng d
020 _a9783642325151
_9978-3-642-32515-1
024 7 _a10.1007/978-3-642-32515-1
_2doi
050 4 _aK4240-4343
050 4 _aK1401-1578.25
072 7 _aLN
_2bicssc
072 7 _aLAW051000
_2bisacsh
082 0 4 _a343.099
_223
100 1 _aAdusei, Poku.
_eauthor.
245 1 0 _aPatenting of Pharmaceuticals and Development in Sub-Saharan Africa
_h[electronic resource] :
_bLaws, Institutions, Practices, and Politics /
_cby Poku Adusei.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg :
_bImprint: Springer,
_c2013.
300 _aXX, 296 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aGeneral introduction and overview -- Exploring the conceptual domains for patent discourse in global trade relations -- Evolutionary trajectories of patents and the politics of exclusion in Sub-Saharan Africa -- The ‘myth’ of patent justifications: triumph and failure dichotomy in the north and south -- Patent regulatory and institutional mechanisms in Sub-Saharan Africa -- Pharmaceutical patents, the right to health, and constitutional supremacy in Sub-Saharan Africa -- Pharmaceutical patents and human development in Sub-Saharan Africa -- General conclusions.
520 _aThis book critically investigates the patent protection of medication in light of the threats posed by HIV/AIDS, malaria and tuberculosis epidemics to the citizens of countries in Sub-Saharan Africa (hereinafter “SSA” or “Africa”). The book outlines the systemic problems associated with the prevailing globalized patent regime and the regime’s inability to promote access to life-saving medication at affordable prices in SSA. It argues that for pharmaceutical patents to retain their relevance in SSA countries, human development concepts must be integrated into global patent law- and policy-making. An integrative approach implies developing additional public health and human development exceptions/limitations to the exercise of patent rights with the goal of scaling up access to medication that can treat epidemics in SSA. By drawing on multiple perspectives of laws, institutions, practices, and politics, the book suggests that SSA countries adopt an evidence-based approach to implementing global patent standards in domestic jurisdictions. This evidence-based approach would include mechanisms like local need assessments and the use of empirical data to shape domestic patent law-making endeavors. The approach also implies revising patent rules and policies with a pro-poor and pro-health emphasis, so that medication will be more affordable and accessible to the citizens of SSA countries. It also suggests considering the opinions of individuals and pro-access institutions in enacting crucial pieces of health-related statutes in SSA countries. The approach in this book is sensitive to the public health needs of the citizens affected by epidemics and to the imperative of building local manufacturing facilities for pharmaceutical research and development in SSA.
650 0 _aLaw.
650 0 _aPharmaceutical technology.
650 0 _aPublic health.
650 0 _aInternational law.
650 0 _aTrade.
650 0 _aIntellectual property
_xLaw and legislation.
650 0 _aIndustrial organization.
650 0 _aDevelopment economics.
650 1 4 _aLaw.
650 2 4 _aInternational IT and Media Law, Intellectual Property Law.
650 2 4 _aIndustrial Organization.
650 2 4 _aPublic Health.
650 2 4 _aPharmaceutical Sciences/Technology.
650 2 4 _aInternational Economic Law, Trade Law.
650 2 4 _aDevelopment Economics.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783642325144
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-642-32515-1
912 _aZDB-2-SHU
942 _2Dewey Decimal Classification
_ceBooks
999 _c46189
_d46189